Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6432
    +0.0006 (+0.10%)
     
  • OIL

    83.06
    +0.33 (+0.40%)
     
  • GOLD

    2,403.20
    +5.20 (+0.22%)
     
  • Bitcoin AUD

    100,511.45
    +1,223.41 (+1.23%)
     
  • CMC Crypto 200

    1,368.24
    +55.61 (+4.43%)
     
  • AUD/EUR

    0.6024
    -0.0007 (-0.11%)
     
  • AUD/NZD

    1.0894
    +0.0020 (+0.18%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,256.05
    -138.26 (-0.79%)
     
  • FTSE

    7,879.77
    +2.72 (+0.03%)
     
  • Dow Jones

    37,975.03
    +199.65 (+0.53%)
     
  • DAX

    17,744.55
    -92.85 (-0.52%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

3 Pharma Stocks That Are Too Cheap to Ignore

3 Pharma Stocks That Are Too Cheap to Ignore

Here's why they think Bristol Myers Squibb (NYSE: BMY), Novartis (NYSE: NVS), and Viatris (NASDAQ: VTRS) are too cheap to ignore. Prosper Junior Bakiny (Bristol Myers Squibb): Investors are sometimes wary of undervalued companies.